添加果胶膳食纤维的肠内营养对重症患者免疫功能及胃肠道功能的影响

doi:10.3877/cma.j.issn.1674-6880.2021.06.004

中华危重症医学杂志(电子版) ›› 2021, Vol. 14 ›› Issue (06) : 460 -465. doi: 10.3877/cma.j.issn.1674-6880.2021.06.004

论著

添加果胶膳食纤维的肠内营养对重症患者免疫功能及胃肠道功能的影响

缪小莉¹, 叶纪录¹, 濮雪华¹^,^†(

), 侯斌¹, 石志祥², 朱进³, 顾志林⁴

^1. 225399　江苏泰州，泰州市人民医院重症医学科
^2. 225511　江苏泰州，泰州市第二人民医院重症医学科
^3. 225399　江苏泰州，泰州市第四人民医院重症医学科
^4. 225599　江苏泰州，泰州市姜堰中医院重症医学科

收稿日期:2021-04-01 出版日期:2021-12-31
通信作者: 濮雪华
基金资助:
真实世界研究专项基金临床科研资助项目(ZC-2019-ICU-057)

Effect of enteral nutrition with pectin dietary fiber on immune and gastrointestinal functions in severe patients

Xiaoli Miao¹, Jilu Ye¹, Xuehua Pu¹^,^†(), Bin Hou¹, Zhixiang Shi², Jin Zhu³, Zhilin Gu⁴

^1. Department of Critical Care Medicine, Taizhou People's Hospital, Taizhou 225399, China
^2. Department of Critical Care Medicine, Taizhou Second People's Hospital, Taizhou 225511, China
^3. Department of Critical Care Medicine, Taizhou Fourth People's Hospital, Taizhou 225399, China
^4. Department of Critical Care Medicine, Jiangyan Hospital of Traditional Chinese Medicine in Taizhou City, Taizhou 225599, China

Received:2021-04-01 Published:2021-12-31
Corresponding author: Xuehua Pu

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

缪小莉, 叶纪录, 濮雪华, 侯斌, 石志祥, 朱进, 顾志林. 添加果胶膳食纤维的肠内营养对重症患者免疫功能及胃肠道功能的影响[J/OL]. 中华危重症医学杂志(电子版), 2021, 14(06): 460-465.

Xiaoli Miao, Jilu Ye, Xuehua Pu, Bin Hou, Zhixiang Shi, Jin Zhu, Zhilin Gu. Effect of enteral nutrition with pectin dietary fiber on immune and gastrointestinal functions in severe patients[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2021, 14(06): 460-465.

目的

探究添加果胶膳食纤维的肠内营养对重症患者免疫功能和肠道功能的影响。

方法

将4家医院2019年9月至2020年8月收治的140例重症患者分为对照组和观察组，每组各70例。对照组患者在基础治疗上予以常规肠内营养治疗，观察组在基础治疗上予以添加果胶膳食纤维的肠内营养治疗。对比两组患者治疗前后血清总蛋白、白蛋白、前白蛋白及血红蛋白的水平，CD3⁺、CD4⁺及CD8⁺的比率及肠道菌群菌落数，并统计治疗期间胃肠道并发症发生情况。

结果

治疗前，两组患者血清总蛋白、白蛋白、前白蛋白、血红蛋白水平，外周血T淋巴细胞亚群CD3⁺、CD4⁺、CD8⁺比率，粪便中双歧杆菌、乳酸杆菌、肠球菌及肠杆菌数目的比较，差异均无统计学意义（P均> 0.05）。与同组治疗前相比，治疗后对照组及观察组患者血清总蛋白、白蛋白、前白蛋白、血红蛋白水平，外周血T淋巴细胞亚群CD3⁺、CD4⁺比率，粪便中双歧杆菌、乳酸杆菌数目均显著升高；CD8⁺比率，粪便中肠球菌、肠杆菌数目均显著降低（P均< 0.05）。且治疗后观察组血清总蛋白[（64 ± 6）g / L vs. （60 ± 6）g / L，t = 4.065，P < 0.001]、白蛋白[（36 ± 5）g / L vs. （33 ± 5）g / L，t = 3.255，P = 0.001]、前白蛋白[（144 ± 27）g / L vs. （120 ± 23）g / L，t = 5.661，P < 0.001]和血红蛋白[（106 ± 18）g / L vs. （99 ± 16）g / L，t = 2.372，P = 0.019]水平，外周血T淋巴细胞亚群CD4⁺比率[（43 ± 6）% vs. （37 ± 6）%，t = 5.709，P < 0.001]，粪便中双歧杆菌[（6.6 ± 0.8）lgCFU / g vs. （4.8 ± 0.6）lgCFU / g，t = 14.503，P < 0.001]、乳酸杆菌[（7.8 ± 0.9）lgCFU / g vs. （6.1 ± 0.8）lgCFU / g，t = 11.689，P < 0.001]数目均显著高于对照组；CD3⁺[（64 ± 7）% vs. （69 ± 8）%，t = 6.045，P < 0.001]、CD8⁺[（21 ± 4）% vs. （25 ± 4）%，t = 6.765，P < 0.001]比率，粪便中肠球菌[（3.2 ± 0.5）lgCFU / g vs. （4.7 ± 0.6）lgCFU / g，t = 15.021，P < 0.001]、肠杆菌[（4.3 ± 0.6）lgCFU / g vs. （6.9 ± 0.8）lgCFU / g，t = 22.190，P < 0.001]数目均显著低于对照组。同时，观察组患者治疗期间腹胀、腹泻、呕吐、便秘、反流及吸入性肺炎的发生率均明显低于对照组（ χ² = 37.428、19.606、15.035、10.570、9.115、6.269，P均< 0.05）。

结论

添加果胶膳食纤维的肠内营养能够提高重症患者的营养状况，改善患者的免疫功能，减少胃肠道并发症的发生。

关键词: 膳食纤维, 肠道营养, 营养支持, 免疫, 胃肠道

Objective

To explore the effect of enteral nutrition with pectin dietary fiber on immune and gastrointestinal functions in severe patients.

Methods

A total of 140 severe patients admitted to four hospitals from September 2019 to August 2020 were randomly divided into a control group and an observation group, with 70 cases in each group. Patients in the control group were treated with routine enteral nutrition in addition to basic treatment, while patients in the observation group were treated with enteral nutrition with pectin dietary fiber in addition to basic treatment. The levels of serum total protein, albumin, prealbumin and hemoglobin, the ratios of CD3⁺, CD4⁺ and CD8⁺ in peripheral blood T lymphocyte subsets, and the numbers of Bifidobacterium, Lactobacillus, Enterococcus and Enterobacter in feces were compared between the two groups before and after treatment. The incidence of gastrointestinal complications during the treatment was counted.

Results

Before the treatment, the levels of serum total protein, albumin, prealbumin and hemoglobin, the ratios of CD3⁺, CD4⁺ and CD8⁺, and the numbers of Bifidobacterium, Lactobacillus, Enterococcus and Enterobacter in feces all showed no significant differences between the two groups (all P > 0.05). After the treatment, the levels of serum total protein, albumin, prealbumin and hemoglobin, the ratios of CD3⁺ and CD4⁺, and the numbers of Bifidobacterium and Lactobacillus in feces were much higher, and the ratio of CD8⁺ and the numbers of Enterococcus and Enterobacter in feces were much lower than those before the treatment in the control group and observation group (all P < 0.05). In the observation group, the levels of serum total protein [(64 ± 6) g / L vs. (60 ± 6) g / L, t = 4.065, P < 0.001], albumin [(36 ± 5) g / L vs. (33 ± 5) g / L, t = 3.255, P = 0.001], prealbumin [(144 ± 27) g / L vs. (120 ± 23) g / L, t = 5.661, P < 0.001] and hemoglobin [(106 ± 18) g / L vs. (99 ± 16) g / L, t = 2.372, P = 0.019], the ratio of CD4⁺ [(43 ± 6)% vs. (37 ± 6)%, t = 5.709, P < 0.001], and the numbers of Bifidobacteriu [(6.6 ± 0.8) lgCFU / g vs. (4.8 ± 0.6) lgCFU / g, t = 14.503, P < 0.001] and Lactobacillu[(7.8 ± 0.9) lgCFU / g vs. (6.1 ± 0.8) lgCFU / g, t = 11.689, P < 0.001] in feces increased markedly, and the ratios of CD3⁺ [(64 ± 7)% vs. (69 ± 8)%, t = 6.045, P < 0.001] and CD8⁺ [(21 ± 4)% vs. (25 ± 4)%, t = 6.765, P < 0.001] and the numbers of Enterococcus [(3.2 ± 0.5) lgCFU / g vs. (4.7 ± 0.6) lgCFU / g, t = 15.021, P < 0.001] and Enterobacter [(4.3 ± 0.6) lgCFU / g vs. (6.9 ± 0.8) lgCFU / g, t = 22.190, P < 0.001] in feces decreased obviously as compared with the control group after the treatment. Meanwhile, the incidence of abdominal distention, diarrhea, vomiting, constipation, reflux and aspiration pneumonia in the observation group was much lower than that in the control group ( χ² = 37.428, 19.606, 15.035, 10.570, 9.115, 6.269; all P < 0.05).

Conclusion

The enteral nutrition with pectin dietary fiber can improve the nutritional status and immune function, and reduce the occurrence of gastrointestinal complications in severe patients.

Key words: Dietary fiber, Enteral nutrition, Nutritional support, Immunity, Gastrointestinal tract

表1 两组重症患者治疗前后营养状况相关指标的比较（± s）

组别		例数	总蛋白（g / L）	白蛋白（g / L）	前白蛋白（mg / L）	血红蛋白（g / L）
对照组
	治疗前	70	49 ± 5	25 ± 4	87 ± 14	90 ± 15
	治疗后	70	60 ± 6^a	33 ± 5^a	120 ± 23^a	99 ± 16^a
观察组
	治疗前	70	50 ± 5	26 ± 4	87 ± 13	90 ± 15
	治疗后	70	64 ± 6^ab	36 ± 5^ab	144 ± 27^ab	106 ± 18^ab

表1 两组重症患者治疗前后营养状况相关指标的比较（± s）

组别		例数	总蛋白（g / L）	白蛋白（g / L）	前白蛋白（mg / L）	血红蛋白（g / L）
对照组
	治疗前	70	49 ± 5	25 ± 4	87 ± 14	90 ± 15
	治疗后	70	60 ± 6^a	33 ± 5^a	120 ± 23^a	99 ± 16^a
观察组
	治疗前	70	50 ± 5	26 ± 4	87 ± 13	90 ± 15
	治疗后	70	64 ± 6^ab	36 ± 5^ab	144 ± 27^ab	106 ± 18^ab

表2 两组重症患者治疗前后免疫功能相关指标的比较（%，± s）

组别		例数	CD3⁺	CD4⁺	CD8⁺
对照组
	治疗前	70	59 ± 7	34 ± 5	30 ± 5
	治疗后	70	69 ± 8^a	37 ± 6^a	25 ± 4^a
观察组
	治疗前	70	60 ± 7	34 ± 5	30 ± 4
	治疗后	70	64 ± 7^ab	43 ± 6^ab	21 ± 4^ab

表2 两组重症患者治疗前后免疫功能相关指标的比较（%，± s）

组别		例数	CD3⁺	CD4⁺	CD8⁺
对照组
	治疗前	70	59 ± 7	34 ± 5	30 ± 5
	治疗后	70	69 ± 8^a	37 ± 6^a	25 ± 4^a
观察组
	治疗前	70	60 ± 7	34 ± 5	30 ± 4
	治疗后	70	64 ± 7^ab	43 ± 6^ab	21 ± 4^ab

表3 两组重症患者治疗前后肠道菌群菌落数的比较（lgCFU / g，± s）

组别		例数	双歧杆菌	乳酸杆菌	肠球菌	肠杆菌
对照组
	治疗前	70	3.2 ± 0.5	4.2 ± 0.6	7.0 ± 0.9	11.0 ± 1.2
	治疗后	70	4.8 ± 0.6^a	6.1 ± 0.8^a	4.7 ± 0.6^a	6.9 ± 0.8^a
观察组
	治疗前	70	3.2 ± 0.5	4.3 ± 0.7	7.0 ± 0.9	11.1 ± 1.3
	治疗后	70	6.6 ± 0.8^ab	7.8 ± 0.9^ab	3.2 ± 0.5^ab	4.3 ± 0.6^ab

表3 两组重症患者治疗前后肠道菌群菌落数的比较（lgCFU / g，± s）

组别		例数	双歧杆菌	乳酸杆菌	肠球菌	肠杆菌
对照组
	治疗前	70	3.2 ± 0.5	4.2 ± 0.6	7.0 ± 0.9	11.0 ± 1.2
	治疗后	70	4.8 ± 0.6^a	6.1 ± 0.8^a	4.7 ± 0.6^a	6.9 ± 0.8^a
观察组
	治疗前	70	3.2 ± 0.5	4.3 ± 0.7	7.0 ± 0.9	11.1 ± 1.3
	治疗后	70	6.6 ± 0.8^ab	7.8 ± 0.9^ab	3.2 ± 0.5^ab	4.3 ± 0.6^ab

表4 两组重症患者治疗期间胃肠道并发症发生情况的比较[例（%）]

组别	例数	腹胀	腹泻	呕吐	便秘	导管阻塞	反流	吸入性肺炎
对照组	70	40（57.14）	27（38.57）	20（28.57）	18（25.71）	3（4.29）	11（15.71）	6（8.57）
观察组	70	6（8.57）	5（7.14）	3（4.29）	4（5.71）	8（11.43）	1（1.43）	0（0.00）
χ²值		37.428	19.606	15.035	10.570	2.467	9.115	6.269
P值		< 0.001	< 0.001	< 0.001	0.001	0.116	0.003	0.012

表4 两组重症患者治疗期间胃肠道并发症发生情况的比较[例（%）]

组别	例数	腹胀	腹泻	呕吐	便秘	导管阻塞	反流	吸入性肺炎
对照组	70	40（57.14）	27（38.57）	20（28.57）	18（25.71）	3（4.29）	11（15.71）	6（8.57）
观察组	70	6（8.57）	5（7.14）	3（4.29）	4（5.71）	8（11.43）	1（1.43）	0（0.00）
χ²值		37.428	19.606	15.035	10.570	2.467	9.115	6.269
P值		< 0.001	< 0.001	< 0.001	0.001	0.116	0.003	0.012

1	Lew CCH, Yandell R, Fraser RJL, et al. Association between malnutrition and clinical outcomes in the intensive care unit: a systematic review[J]. JPEN J Parenter Enteral Nutr, 2017, 41 (5): 744-758.
2	Jiang L, Huang X, Wu C, et al. The effects of an enteral nutrition feeding protocol on critically ill patients: a prospective multi-center, before-after study[J]. J Crit Care, 2020 (56): 249-256.
3	Hiura G, Lebwohl B, Seres DS. Malnutrition diagnosis in critically ill patients using 2012 academy of nutrition and dietetics / American society for parenteral and enteral nutrition standardized diagnostic characteristics is associated with longer hospital and intensive care unit length of stay and increased in-hospital mortality[J]. JPEN J Parenter Enteral Nutr, 2020, 44 (2): 256-264.
4	Mehta Y, Mithal A, Kulkarni A, et al. Practice gui-delines for enteral nutrition management in dysglycemic critically ill patients: a relook for Indian scenario[J]. Indian J Crit Care Med, 2019, 23 (12): 594-603.
5	张庆男，钱宵佳，陈洁. 危重症患者肠内营养喂养不耐受的影响因素及对策[J]. 中国老年学杂志，2019，39(18):4516-4518.
6	Tao G, Min-Hua C, Feng-Chan X, et al. Changes of plasma acetylcholine and inflammatory markers in critically ill patients during early enteral nutrition: a prospective observational study[J]. J Crit Care, 2019 (52): 219-226.
7	袁计红，袁玲红，王谊，等. 肠内营养中添加膳食纤维对重症急性胰腺炎患者炎症反应、免疫应答及肠黏膜屏障的影响[J]. 海南医学院学报，2019，25(1):24-28.
8	Fu Y, Moscoso DI, Porter J, et al. Relationship be-tween dietary fiber intake and short-chain fatty acid-producing bacteria during critical illness: a prospective cohort study[J]. JPEN J Parenter Enteral Nutr, 2020, 44 (3): 463-471.
9	Singer P, Blaser AR, Berger MM, et al. ESPEN gui-deline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38 (1): 48-79.
10	蔡旗旗，张盛，葛小刚，等. 免疫增强型肠内营养乳剂对机械通气危重症患者免疫功能的影响[J]. 中国中西医结合急救杂志，2018，25(2):169-172.
11	Singer P. Preserving the quality of life: nutrition in the ICU[J]. Crit Care, 2019, 23 (Suppl 1): 139.
12	潘小东，张京臣，汤鲁明，等. 鼻胃管减压联合鼻肠管营养支持对重症神经系统疾病患者预后的影响[J/CD]. 中华危重症医学杂志（电子版），2017，10(4):230-234.
13	Ortiz-Reyes LA, Chang Y, Quraishi SA, et al. Early enteral nutrition adequacy mitigates the neutrophil-lymphocyte ratio improving clinical outcomes in critically ill surgical patients[J]. Nutr Clin Pract, 2019, 34 (1): 148-155.
14	Li H, Yang Z, Tian F, et al. Risk factors associated with intolerance to enteral nutrition in moderately severe acute pancreatitis: a retrospective study of 568 patients[J]. Saudi J Gastroenterol, 2019, 25 (6): 362-368.
15	Flint HJ, Scott KP, Louis P, et al. The role of the gut microbiota in nutrition and health[J]. Nat Rev Gastroenterol Hepatol, 2012, 9 (10): 577-589.
16	Khosravi A, Yanez A, Price JG, et al. Gut microbiota promote hematopoiesis to control bacterial infection[J]. Cell Host Microbe, 2014, 15 (3): 374-381.
17	郑松柏，卢萌. 膳食纤维与老年人肠黏膜屏障及肠内外相关疾病[J]. 中华老年医学杂志，2017，36(3):238-241.
18	Xu R, Ding Z, Zhao P, et al. The effects of early post-operative soluble dietary fiber enteral nutrition for colon cancer[J]. Nutrients, 2016, 8 (9): 584.
19	Ye MB, Lim BO. Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice[J]. J Agric Food Chem, 2010, 58 (21): 11281-11286.
20	Fu Y, Moscoso DI, Porter J, et al. Relationship be-tween dietary fiber intake and short-chain fatty acid-producing bacteria during critical illness: a prospective cohort study[J]. JPEN J Parenter Enteral Nutr, 2020, 44 (3): 463-471.
21	米元元，黄海燕，尚游，等. 中国危重症患者肠内营养治疗常见并发症预防管理专家共识（2021版）[J]. 中华危重病急救医学，2021，33(8):903-918.
22	Kitaguchi K, Yabe T. Dietary fiber pectin is reco-gnized in a structure-specific manner by intestinal cells[J]. Trends in Glycoscience and Glycotechnology, 2019, 31 (182): E91-E97.
23	Zhao R, Wang Y, Huang Y, et al. Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients: a prospective randomized and controlled trial[J]. Medicine (Baltimore), 2017, 96 (43): e8418.
24	Taylor BE, McClave SA, Martindale RG, et al. Gui-delines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)[J]. Critical Care Medicine, 2016, 44 (2): 390-438.
25	宿英英，潘速跃，彭斌，等. 神经系统疾病肠内营养支持中国专家共识（第二版）[J]. 中华临床营养杂志，2019，27(4):193-203.
26	陆军，赵滋苗，王飞，等. 高膳食纤维肠内营养改善危重症患者营养状况及耐受[J/CD]. 中华危重症医学杂志（电子版），2011，4(5):300-305.
27	Tatsumi H. Enteral tolerance in critically ill patients[J]. J Intensive Care, 2019 (7): 30-38.

[1]	杨桂清, 孟静静. 哺乳期亚临床乳腺炎的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 376-379.
[2]	戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.
[3]	张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[4]	梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5]	张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6]	司钦亮, 毕世龙, 焦慧骁, 李世照, 陈哲禹, 武玉东. 精索去分化脂肪肉瘤两例并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 585-590.
[7]	林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊（第15期）——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[8]	王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[9]	中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[10]	陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[11]	魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治（附四例报告）[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[12]	张龙, 孙善柯, 徐伟, 李文柱, 李俊达, 池涌泉, 何广胜, 成峰, 王学浩, 饶建华. 腹腔镜脾切除治疗血液系统疾病的临床疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 870-875.
[13]	董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14]	谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[15]	王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effect of enteral nutrition with pectin dietary fiber on immune and gastrointestinal functions in severe patients

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effect of enteral nutrition with pectin dietary fiber on immune and gastrointestinal functions in severe patients